Vir Biotechnology VIR
NASDAQ VIR
$11.17 -0.12 (-1.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Asset Writedowns and Impairment (2023 - 2024)

Updated

Vir Biotechnology (VIR) reported Asset Writedowns and Impairment of $11.04 million for Q4 2024, up 300.1% from $2.76 million a year earlier.

Analysis

Vir Biotechnology (VIR) Asset Writedowns and Impairment (2023 - 2024) Analysis & Trends

For FY2024, Vir Biotechnology posted Asset Writedowns and Impairment of $14.55 million, up 50.7% from FY2023.

  • Asset Writedowns and Impairment has a four-year compound annual growth rate of 104.5% (FY2020 to FY2024).
  • By year, Asset Writedowns and Impairment came in at $9.66 million in FY2023 and $832,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vir Biotechnology 1.89 Bn 1.89 Bn 238.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 11.04 Mn
Dec 31, 2023 2.76 Mn
API Access

Vir Biotechnology Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VIR&period=max&api_key=YOUR_API_KEY